Cholesterol-lowering statins seem to keep breast cancer at bay in some patients. Now researchers reporting in the January 20th issue of the journal Cell, a Cell Press publication, provide clues about how statins might yield those unexpected benefits. The findings also suggest that mutations in a single gene could be used to identify tumors likely [...]
No Comments »
Filed under: Pharmacy News
Although endocrine therapy for breast cancer has shown excellent results in controlling the disease, responsiveness to the therapy depends on whether or not there is expression of estrogen receptors in breast cancer cells. Research from the Sbarro Institute for Cancer Research and Molecular Medicine, a nonprofit cancer, cardiovascular and diabetes research center located in Philadelphia, [...]
No Comments »
Filed under: Pharmacy News
Using two drugs that inhibit the growth factor HER2 for preoperative treatment of early-stage HER2-positive breast cancer appears to have better results than treatment with a single agent. In a report in the January 17 issue of The Lancet, an international research team reports that a protocol adding lapatinib (Tykerb) to trastuzumab (Herceptin) was more [...]
No Comments »
Filed under: Pharmacy News
A new study led by the University of Reading in the UK that examined breast tissue samples from 40 women who underwent mastectomies for breast cancer, found they contained widespread traces of parabens, preservatives commonly used in deodorants, make-up, body lotions, moisturisers and many other cosmetic products…
No Comments »
Filed under: Women's Health
The data are preliminary, but red wine appears to act as a nutritional aromatase inhibitor and does not appear to increase the risk for breast cancer. Medscape Medical News
No Comments »
Filed under: General Health News
Do methodology problems underlie clinical trials that conclude that mammography screening is a failure? Medscape Radiology
No Comments »
Filed under: General Health News
Eisai Inc. announced today that the Centers for Medicare and Medicaid Services (CMS) has assigned a unique, permanent Healthcare Common Procedure Coding System (HCPCS) J-code for Halaven (eribulin mesylate) Injection.
No Comments »
Filed under: Pharmacy News
(MedPage Today) — As part of the Year in Review series, MedPage Today reporters are revisiting major news stories and following up with an analysis of the impact of the original report, as well as subsequent news generated by the initial publication. Here’s what’s happened with primary prevention in breast cancer since the MAP.3 results [...]
No Comments »
Filed under: General Health News
(MedPage Today) — Our Year in Review series highlights the major medical news stories of 2011. The announcement of study results showing a 65% decrease in first breast cancers among postmenopausal women at moderate or high risk of the disease brought expectations that more women would be placed on chemoprevention. Here, again, is the original [...]
No Comments »
Filed under: General Health News
McMaster University researchers have found consistent evidence that use of hormone replacement therapy (HRT) is associated with breast cancer globally. This study comes at a time when more women are again asking for this medication to control hot flashes and other symptoms of menopause. The rising trend is at odds with a U.S…
No Comments »
Filed under: Women's Health
